Determinants of type of step-up treatment following medium-dose ICS/LABA in asthma patients - TAILOR study
K. Verhamme (Rotterdam, Netherlands), M. De Ridder (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), M. Mosseveld (Rotterdam, Netherlands), L. Pedersen (Aarhus, Denmark), F. Lapi (Florence, Italy), E. Marconi (Florence, Italy), C. Tan (Oxford, United Kingdom), A. Delmestri (Oxford, United Kingdom), D. Prieto-Alhambra (Oxford, United Kingdom), D. Prieto-Alhambra (Rotterdam, Netherlands), E. Nudo (Parma, Italy), G. Brusselle (Ghent, Belgium)
Source: International Congress 2022 – Clinical treatment of asthma
Session: Clinical treatment of asthma
Session type: Thematic Poster
Number: 3869
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Verhamme (Rotterdam, Netherlands), M. De Ridder (Rotterdam, Netherlands), P. Rijnbeek (Rotterdam, Netherlands), M. Mosseveld (Rotterdam, Netherlands), L. Pedersen (Aarhus, Denmark), F. Lapi (Florence, Italy), E. Marconi (Florence, Italy), C. Tan (Oxford, United Kingdom), A. Delmestri (Oxford, United Kingdom), D. Prieto-Alhambra (Oxford, United Kingdom), D. Prieto-Alhambra (Rotterdam, Netherlands), E. Nudo (Parma, Italy), G. Brusselle (Ghent, Belgium). Determinants of type of step-up treatment following medium-dose ICS/LABA in asthma patients - TAILOR study. 3869
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|